News

7 November 2019

EACS is willing to strengthen basic and translational sciences within the 17th European AIDS Conference and is collaborating with the ANRS to organise a special session on HIV cure. This joint session will be held on Thursday, November 7 from 10:00-12:00.

Lectures:
Mechanisms of HIV persistence, Maria Jose Buzón, Spain
Cell metabolism and HIV pathogenesis, Asier Saez-Cirion, France
Antiviral NK cells and HIV-1 immunotherapy, Marcus Altfeld, Germany

Read more on the HIV Cure Symposium

The H.W. & J. Hector Foundation, Weinheim, is creating and  announcing a prize for European HIV research, which will be awarded for the best scientific achievements in the HIV research area in 2019.
Any paper on a HIV-related topic that has been accepted or published in a peer-reviewed journal within the last 24 months (i.e. not later than November 1, 2017) before the start of the 17th European AIDS Conference can be submitted.

The submitted paper should be sent, in electronic version, along with the application letter by June 30, 2019 to the EACS Secretariat at info_at_eacsociety.org.

Read more

The survey is carried out by the European AIDS Treatment Group (EATG) as part of the EmERGE Study (https://www.emergeproject.eu/), and seeks to shed light on the diversity of health services and the uses of m-health solutions to improve the delivery of HIV care in Europe.

Read more and respond to the survey

14-15 June 2019

The 12th edition of the International Symposium on HIV and Neuropsychiatry will take place in Barcelona on 14-15 June 2019.
This Symposium is aimed at those health professionals who have healthcare or scientific interest in promoting health neuropsychological of the HIV-infected patients. It has an eminently practical character designed to the detection and management of the more frequent problems such as depression or neurocognitive deterioration, the knowledge of the neuropsychological effects of the antiretrovirals and adverse effects of psycho medicines and the consideration of the more outstanding interactions between both groups of medicines.

Read more

The Canadian Association for HIV Research (CAHR) is the leading organization of HIV/AIDS researchers in Canada. As an integral element of its mandate, CAHR works to promote education and the development of researchers. As part of this effort, and with the generous support of ViiV Healthcare, CAHR will be offering travel awards for Canadian health care professionals (HCPs) – working in the realm of HIV – to attend the 17th European AIDS Conference.

Read more

7-8 November 2019

We invite you to join the 17th European AIDS Conference plenary lectures! (Basel, Switzerland - 7-8 November 2019 - 8:30-9:30)

The latent HIV-1 reservoir, Matthieu Perreau, Switzerland

New drugs - Who would need them?,Chloe Orkin, United Kingdom

Precision medicine in HIV, Amalio Telenti, United States

Whole genome sequencing for tuberculosis treatment and control: A game changer?, Iñaki Comas, Spain

Read the lecture synopses: https://bit.ly/2IAEMri

www.clinicalcasesDDIs.com will be launched mid-May.

Use of multiple drugs in addition to antiretroviral treatment (polypharmacy) is getting increasingly common in people living with HIV (PLWH). This is partly due to aging and co-morbidities, but also to the use of other substances that may be included in alternative treatments, supplements, steroids, recreational drugs, etc. 

Learn more

6 November 2019

The 17th European AIDS Conference will be launched at the opening ceremony taking place at the Congress Center Basel on Wednesday, November 6, 2019 from 17:15-18:45. We are delighted to announce the keynote speakers and the topics which will set the tone of the Conference. Read more